CRNX as of Nov 2 · 03:00 ET
CRNXNasdaqPharmaceutical Preparations
Crinetics Pharmaceuticals, Inc. · Brief
Next report
3 days
Nov 5 · after closeest.Q3 FY26
Expected move
No implied move.
1 of 8≥ implied
- avg implied
- ±9.2%
- avg realized
- ±6.3%
Feb 27 '25±11.0%▲+7.74%×0.70
May 8 '25±8.8%▼−6.18%×0.70
Aug 7 '25±10.4%▼−3.69%×0.35
Nov 6 '25±10.1%▼−8.02%×0.79
Jan 5 '26±10.1%▼−4.63%×0.46
Q1 FY26±12.4%▼−6.04%×0.49
May 7 '26±9.5%▼−13.82%×1.45
Q2 FY26±1.1%▲+0.12%×0.11
quarterimplied−15%0+15%realized×
Q2 FY26±1.1%▲+0.12%×0.11
May '26±9.5%▼−13.82%×1.45
Q1 FY26±12.4%▼−6.04%×0.49
Jan '26±10.1%▼−4.63%×0.46
Nov '25±10.1%▼−8.02%×0.79
Aug '25±10.4%▼−3.69%×0.35
2 older reports
May '25±8.8%▼−6.18%×0.70
Feb '25±11.0%▲+7.74%×0.70
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 5 report · est.Bull2 of 4
Bear2 of 4
AI captions · Sep 28 '26once per report · top 2 per case
Linked exposure
CRNX report sessionNo linked exposure.
No changes.
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.